CY1110538T1 - S-μιρταζαπινη για τη θεραπεια των εξαψεων - Google Patents
S-μιρταζαπινη για τη θεραπεια των εξαψεωνInfo
- Publication number
- CY1110538T1 CY1110538T1 CY20091101044T CY091101044T CY1110538T1 CY 1110538 T1 CY1110538 T1 CY 1110538T1 CY 20091101044 T CY20091101044 T CY 20091101044T CY 091101044 T CY091101044 T CY 091101044T CY 1110538 T1 CY1110538 T1 CY 1110538T1
- Authority
- CY
- Cyprus
- Prior art keywords
- mirtazapin
- extra treatment
- mirtazapine
- extra
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04105778 | 2004-11-15 | ||
| EP05808013A EP1814555B1 (en) | 2004-11-15 | 2005-11-14 | S-mirtazapine for the treatment of hot flush |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110538T1 true CY1110538T1 (el) | 2015-04-29 |
Family
ID=34929859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091101044T CY1110538T1 (el) | 2004-11-15 | 2009-10-12 | S-μιρταζαπινη για τη θεραπεια των εξαψεων |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US20070265245A1 (enExample) |
| EP (1) | EP1814555B1 (enExample) |
| JP (1) | JP2008519810A (enExample) |
| KR (1) | KR20070085470A (enExample) |
| CN (2) | CN102772414A (enExample) |
| AR (1) | AR053780A1 (enExample) |
| AT (1) | ATE439843T1 (enExample) |
| AU (1) | AU2005303778B2 (enExample) |
| BR (1) | BRPI0517818A2 (enExample) |
| CA (1) | CA2587283C (enExample) |
| CY (1) | CY1110538T1 (enExample) |
| DE (1) | DE602005016141D1 (enExample) |
| DK (1) | DK1814555T3 (enExample) |
| ES (1) | ES2329815T3 (enExample) |
| HR (1) | HRP20090513T1 (enExample) |
| IL (1) | IL182767A (enExample) |
| MX (1) | MX2007005827A (enExample) |
| MY (1) | MY144089A (enExample) |
| NO (1) | NO20072285L (enExample) |
| NZ (1) | NZ554858A (enExample) |
| PE (1) | PE20061051A1 (enExample) |
| PL (1) | PL1814555T3 (enExample) |
| PT (1) | PT1814555E (enExample) |
| RS (1) | RS51138B (enExample) |
| RU (1) | RU2396957C2 (enExample) |
| SI (1) | SI1814555T1 (enExample) |
| TW (1) | TW200631584A (enExample) |
| UA (1) | UA88655C2 (enExample) |
| WO (1) | WO2006051111A1 (enExample) |
| ZA (1) | ZA200703884B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007002174A2 (en) * | 2005-06-27 | 2007-01-04 | N.V. Organon. | A method of treatment of hormone depletion induced vasomotor symptoms |
| US20070129611A1 (en) * | 2005-12-06 | 2007-06-07 | University Of North Texas Health Science Center At Fort Worth | System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms |
| CA2644985A1 (en) * | 2006-03-06 | 2007-09-13 | N.V. Organon | An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms |
| US20100129425A1 (en) * | 2006-11-22 | 2010-05-27 | N.V. Organon | Vaginal delivery system for mirtazapine |
| US7645750B2 (en) * | 2006-12-13 | 2010-01-12 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Method of treating symptoms of hormonal variations |
| JP2009018992A (ja) | 2007-07-10 | 2009-01-29 | Sumitomo Chemical Co Ltd | 光学活性ミルタザピンの製造方法 |
| US8420624B2 (en) | 2007-12-04 | 2013-04-16 | Yung Shin Pharm. Ind. Co., Ltd. | Methods for treating or preventing symptoms of hormonal variations |
| EP3261645B1 (en) | 2015-02-27 | 2021-04-28 | Dechra Limited | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
| EP3630102B1 (en) * | 2017-05-25 | 2024-08-14 | Glytech LLC. | Formulations for treatment of post-traumatic stress disorder |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| US4515792A (en) * | 1982-09-30 | 1985-05-07 | Ciba-Geigy Corporation | Tetracyclic heterocycles and antidepressant compositions thereof |
| JPH1187727A (ja) * | 1997-09-12 | 1999-03-30 | Mitsubishi Electric Corp | 半導体装置 |
| DE69913116T2 (de) * | 1998-04-02 | 2004-06-03 | Akzo Nobel N.V. | Orale flüssige lösung enthaltend das antidepressivum mirtazapine |
| RU2195951C1 (ru) * | 2001-08-20 | 2003-01-10 | Общество с ограниченной ответственностью "Лаборатория "Ирис" | Средство для лечения климактерических расстройств |
-
2005
- 2005-11-10 TW TW094139442A patent/TW200631584A/zh unknown
- 2005-11-14 PL PL05808013T patent/PL1814555T3/pl unknown
- 2005-11-14 PT PT05808013T patent/PT1814555E/pt unknown
- 2005-11-14 SI SI200530802T patent/SI1814555T1/sl unknown
- 2005-11-14 PE PE2005001334A patent/PE20061051A1/es not_active Application Discontinuation
- 2005-11-14 DK DK05808013T patent/DK1814555T3/da active
- 2005-11-14 CN CN2012102639294A patent/CN102772414A/zh active Pending
- 2005-11-14 KR KR1020077011981A patent/KR20070085470A/ko not_active Ceased
- 2005-11-14 US US11/667,579 patent/US20070265245A1/en not_active Abandoned
- 2005-11-14 ES ES05808013T patent/ES2329815T3/es not_active Expired - Lifetime
- 2005-11-14 MX MX2007005827A patent/MX2007005827A/es active IP Right Grant
- 2005-11-14 DE DE602005016141T patent/DE602005016141D1/de not_active Expired - Lifetime
- 2005-11-14 EP EP05808013A patent/EP1814555B1/en not_active Expired - Lifetime
- 2005-11-14 JP JP2007540655A patent/JP2008519810A/ja active Pending
- 2005-11-14 RS RSP-2009/0504A patent/RS51138B/sr unknown
- 2005-11-14 MY MYPI20055321A patent/MY144089A/en unknown
- 2005-11-14 AU AU2005303778A patent/AU2005303778B2/en not_active Expired
- 2005-11-14 AT AT05808013T patent/ATE439843T1/de active
- 2005-11-14 BR BRPI0517818-5A patent/BRPI0517818A2/pt not_active IP Right Cessation
- 2005-11-14 WO PCT/EP2005/055947 patent/WO2006051111A1/en not_active Ceased
- 2005-11-14 CN CNA200580038949XA patent/CN101056641A/zh active Pending
- 2005-11-14 HR HR20090513T patent/HRP20090513T1/xx unknown
- 2005-11-14 NZ NZ554858A patent/NZ554858A/en not_active IP Right Cessation
- 2005-11-14 AR ARP050104768A patent/AR053780A1/es unknown
- 2005-11-14 UA UAA200705135A patent/UA88655C2/ru unknown
- 2005-11-14 CA CA2587283A patent/CA2587283C/en not_active Expired - Fee Related
- 2005-11-14 RU RU2007122391/14A patent/RU2396957C2/ru not_active IP Right Cessation
-
2007
- 2007-04-23 IL IL182767A patent/IL182767A/en not_active IP Right Cessation
- 2007-04-30 NO NO20072285A patent/NO20072285L/no not_active Application Discontinuation
- 2007-05-14 ZA ZA200703884A patent/ZA200703884B/xx unknown
-
2009
- 2009-10-12 CY CY20091101044T patent/CY1110538T1/el unknown
-
2010
- 2010-07-01 US US12/828,720 patent/US20100267694A1/en not_active Abandoned
-
2012
- 2012-08-09 US US13/570,481 patent/US20120302552A1/en not_active Abandoned
-
2013
- 2013-04-05 US US13/857,445 patent/US20130225559A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110538T1 (el) | S-μιρταζαπινη για τη θεραπεια των εξαψεων | |
| CY1124144T1 (el) | Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης | |
| CY1115299T1 (el) | Αναστολεις mtor στη θεραπεια των ενδοκρινικων ογκων | |
| CY1109741T1 (el) | Sns-595 και μεθοδοι χρησης αυτου | |
| CY1114401T1 (el) | Αντιμετωπιση τυπου 2 διαβητη με ενα συνδυασμο dpiv αναστολεα και μετφορμινης ή θειαζολιδινοδιονης | |
| CY1118472T1 (el) | Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων | |
| CY1120961T1 (el) | Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος | |
| CY1117817T1 (el) | Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων | |
| CY1115059T1 (el) | Θεραπευτικα απταμερη χρησιμα στην θεραπευτικη αγωγη διαταραχων σχετιζομενων με συμπληρωμα | |
| CY1110889T1 (el) | C-αρυλο γλυκοζιτικοι sglt2 αναστολεις και μεθοδος για την παραγωγη τους | |
| CY1115871T1 (el) | Μεθοδοι για την αντιμετωπιση ουρικης αρθριτιδας | |
| CY1115381T1 (el) | Διενυδρη υδροχλωρικη ναλμεφαινη | |
| CY1118349T1 (el) | Παραγοντες συνδεσης me cd19 και χρησεις αυτων | |
| ATE539752T1 (de) | Verwendung von pi3k- und mek-modulatoren bei der krebsbehandlung | |
| CY1113426T1 (el) | Παραγωγα βενζοθειαζεπινης ως αναστολεις υποδοχεα ρυανοδινης (ryr2) και χρηση αυτων στη θεραπεια καρδιακων ασθενειων | |
| ATE541597T1 (de) | Implantierbare vorrichtung mit sich langsam auflösendem polymer | |
| CY1109240T1 (el) | Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο | |
| CY1106386T1 (el) | Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης | |
| AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
| CY1124281T1 (el) | Θεραπευτικη χρηση ειδικου προσδετη σε σχετικες me msrv ασθενειες | |
| CY1114920T1 (el) | Φαρμακευτικη συνθεση που περιεχει λακοσαμιδη και λεβετιρακεταμη με συνεργιστικη αντισπασμωδικη δραση | |
| CY1113930T1 (el) | Ενωσεις χρησιμες στην αναστολη της chk1 | |
| CY1115566T1 (el) | Παραγωγα phenoxypyridinyl amide και η χρηση τους στην θεραπεια καταστασεων ασθενειας με την μεσολαβηση της pde4 | |
| CY1111161T1 (el) | Χρηση βενζο-συγχωνευμενων ετεροκυκλικων παραγωγων σουλφαμιδιου για τη μειωση των λιπιδιων και τη μειωση των επιπεδων της γλυκοζης στο αιμα | |
| CY1112288T1 (el) | Θεραπεια του καρκινου με αντισωματα κατα της il-1a |